CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $11.3M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$413K | |
| 2 | +$322K | |
| 3 | +$311K | |
| 4 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$131K |
| 5 |
Morgan Stanley
New York
|
+$62.3K |
Top Sellers
| 1 | -$297K | |
| 2 | -$119K | |
| 3 | -$88.8K | |
| 4 |
LPL Financial
San Diego,
California
|
-$81.8K |
| 5 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
-$31.4K |